There are numerous health issues that can lead to a patient being hemodynamically unstable, and it can be scary for the patient and their loved ones to realise that the onset of organ failure can be sudden, giving physicians little to no time to react.

According to the CDC, approximately 6.2 million adults in the United States have heart failure. While there are symptoms to look out for, such as changes in weight, fatigue and shortness of breath, changes in hemodynamics can precede symptoms by days or weeks, offering the opportunity for early detection and treatment.

Implantable monitoring devices can detect changes in pulmonary-artery pressure for earlier intervention and management. These systems consist of an implantable pulmonary-artery sensor and a fine-wire transmission system, allowing patients to send readings directly to a physician where it can be assessed and factors such as medication can be modified if needed.

Patients with hemodynamic monitoring devices are considerably less likely to require hospitalisation and gives them peace of mind and not have to wait for negative symptoms to present themselves. As an implantable device, these are relatively new solutions, so manufacturers are continually developing new designs that are non-invasive, safe and effective.

The wire components in these devices are vitally important, as changes to pulmonary-artery pressure must be reliably sensed and transmitted for the device to work. With more than  200 alloy materials and a specialisation in choosing the best configurations, Sandvik Material Technology’s EXERA® wire-based components are used for a variety of applications, from vascular therapy to biosensing and cochlear remediation. Customers can choose from an extensive range of materials, sizes, surface treatments and product forms to work with Sandvik and develop medical-grade ultra-fine wire for their medical devices.

For more information about EXERA® fine medical wire-components, including available materials and surface treatments, download the white paper below.